Therefore, this study aims to apply evidence-based medicine principles and methods to conduct a comprehensive analysis of all published studies on the relationship between XRCC3 Thr241Met polymorphism and genetic susceptibility to pancreatic cancer. This evidence concerns the gene XRCC3 and familial pancreatic carcinoma.